Contineum Therapeutics Inc (CTNM)

05:14 AM

Contineum Therapeutics stock downgraded by Morgan Stanley on IPF drug concerns - Investing.com

05:14 AM

Jan 07, 2026

Contineum Therapeutics stock drops as company prices upsized $90 million offering - MSN

Jan 07, 2026

Jan 07, 2026

What sentiment indicators say about Contineum Therapeutics Inc. stockSector Performance Review & Explosive Capital Gains - ulpravda.ru

Jan 07, 2026

Jan 07, 2026

Contineum Therapeutics, Inc. (CTNM) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Jan 07, 2026

Jan 06, 2026

Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jan 06, 2026

Dec 31, 2025

Wall Street Analysts See a 91.49% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High? - Finviz

Dec 31, 2025

Dec 30, 2025

Lorrain, Contineum Therapeutics CSO, sells $51k in stock - Investing.com India

Dec 30, 2025

Dec 30, 2025

Lorrain, Contineum Therapeutics CSO, sells $51k in stock By Investing.com - Investing.com Australia

Dec 30, 2025

Dec 26, 2025

Contineum Therapeutics announces proposed $75M public offering - MSN

Dec 26, 2025

Dec 26, 2025

Contineum Therapeutics Submits Phase 2 Trial for PIPE-791 - MSN

Dec 26, 2025

Dec 26, 2025

Contineum Therapeutics Reports Increased R&D Investment Amid Losses - MSN

Dec 26, 2025

Dec 22, 2025

Contineum Therapeutics, Inc.(NasdaqGS: CTNM) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 22, 2025

Dec 21, 2025

Aug Sentiment: Why Contineum Therapeutics Inc. stock is seen as undervaluedInflation Watch & Reliable Intraday Trade Alerts - Улправда

Dec 21, 2025

Dec 21, 2025

Contineum Therapeutics (NASDAQ:CTNM) Raised to Hold at Wall Street Zen - MarketBeat

Dec 21, 2025

Dec 20, 2025

Why analysts remain bullish on Contineum Therapeutics Inc. stockMarket Movers & Expert Approved Trade Ideas - Улправда

Dec 20, 2025

Dec 20, 2025

Why retail investors favor Contineum Therapeutics Inc. stockJuly 2025 Summary & Daily Chart Pattern Signals - Улправда

Dec 20, 2025

Dec 20, 2025

Why Contineum Therapeutics Inc. stock attracts high net worth investorsWeekly Trend Report & Free Long-Term Investment Growth Plans - Улправда

Dec 20, 2025

Dec 20, 2025

How risky is Contineum Therapeutics Inc. stock now2025 Trading Volume Trends & Low Risk Entry Point Tips - Улправда

Dec 20, 2025

Dec 19, 2025

Why Contineum Therapeutics Inc. stock is seen as undervaluedWeekly Profit Recap & Free Technical Pattern Based Buy Signals - Улправда

Dec 19, 2025

Dec 19, 2025

What risks investors should watch in Contineum Therapeutics Inc. stockOptions Play & Weekly Setup with ROI Potential - Улправда

Dec 19, 2025

Dec 19, 2025

Published on: 2025-12-19 19:15:06 - Улправда

Dec 19, 2025

Dec 19, 2025

Why Contineum Therapeutics Inc. stock remains undervaluedEntry Point & Smart Money Movement Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Aug Breakouts: Why Contineum Therapeutics Inc. stock is seen as undervalued2025 Earnings Impact & Capital Efficient Trading Techniques - Улправда

Dec 19, 2025

Dec 19, 2025

Published on: 2025-12-19 11:46:29 - Улправда

Dec 19, 2025

Dec 19, 2025

Can Contineum Therapeutics Inc. stock deliver strong Q4 earnings2025 Geopolitical Influence & Safe Entry Point Identification - DonanımHaber

Dec 19, 2025

Dec 15, 2025

Contineum Therapeutics Earnings Notes - Trefis

Dec 15, 2025

Dec 14, 2025

EBITDA per share of Contineum Therapeutics, Inc. – NASDAQ:CTNM - TradingView — Track All Markets

Dec 14, 2025

Dec 13, 2025

Great Week for Contineum Therapeutics, Inc. (NASDAQ:CTNM) Institutional Investors After Losing 5.3% Over the Previous Year - 富途牛牛

Dec 13, 2025

Dec 13, 2025

Contineum Therapeutics (NASDAQ:CTNM) Stock Rating Lowered by Wall Street Zen - MarketBeat

Dec 13, 2025

Dec 12, 2025

Contineum Therapeutics Inc trading resumes - MSN

Dec 12, 2025

Dec 12, 2025

Contineum price target lowered to $22 from $25 at RBC Capital - MSN

Dec 12, 2025

Dec 12, 2025

Contineum Therapeutics Prices Upsized $90 Million Class A Share Offering - marketscreener.com

Dec 12, 2025

Dec 12, 2025

Contineum prices upsized public offering of common stock at $12.25 per share - Investing.com Nigeria

Dec 12, 2025

Dec 12, 2025

Contineum Therapeutics, Inc. (NASDAQ:CTNM) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Dec 12, 2025

Dec 12, 2025

Contineum Therapeutics, Inc. (NASDAQ:CTNM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 12, 2025

Dec 11, 2025

Contineum prices upsized public offering of common stock at $12.25 per share By Investing.com - Investing.com South Africa

Dec 11, 2025

Dec 11, 2025

Contineum Therapeutics prices upsized $90 million public offering at $12.25 per share - marketscreener.com

Dec 11, 2025

Dec 11, 2025

Contineum Therapeutics (NASDAQ: CTNM) sets price for upsized $90.0M offering - Stock Titan

Dec 11, 2025

Dec 11, 2025

Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering - Business Wire

Dec 11, 2025

Dec 11, 2025

Contineum Therapeutics launches $75 million public offering of stock By Investing.com - Investing.com Nigeria

Dec 11, 2025

Dec 11, 2025

Contineum Therapeutics launches $75 million public offering of stock - Investing.com

Dec 11, 2025

Dec 11, 2025

Contineum Therapeutics falls on planned $75 million share sale - TradingView — Track All Markets

Dec 11, 2025

Dec 11, 2025

Contineum Therapeutics Announces Proposed $75.0 Million Public Offering - Business Wire

Dec 11, 2025

Dec 10, 2025

ETFs Investing in Contineum Therapeutics, Inc. Stocks - TradingView — Track All Markets

Dec 10, 2025

Dec 09, 2025

Contineum Therapeutics, Inc. (NASDAQ:CTNM) institutional owners may be pleased with recent gains after 16% loss over the past year - simplywall.st

Dec 09, 2025